Please Wait...

PIIANP // Procollagen Type IIA N-Propeptide

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Type II collagen constitute 60% of cartilage weight and is found exclusively in cartilaginous tissues. Type II pro-collagen is subjected to differential splicing and produces two forms of amino-pro-peptide: PIIANP and PIIBNP, containing respectively the type IIA and type IIB exons (Rousseau, 2004). The IIB form is lacking the domain codded by exon 2: a 69-amino-acid cysteine-rich globular domain (Garnero et al., 2002). PIIANP can be specifically measured and is a biomarker for a collagen type II synthesis (Elsaid and Chichester, 2006; Rousseau, 2004).

Bioclinica Lab employs a manual competitive immunoassay for the measurement of PIIANP in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a… https://t.co/VRIhWWf4tE
Bioclinica (5 days ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour… https://t.co/7ACrv8cvuF
Bioclinica (1 week ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff… https://t.co/vFhC7ITfZV
Bioclinica (2 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app… https://t.co/TJt2sZlrFP
Bioclinica (2 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/qIpi1MESXw
Bioclinica (3 weeks ago)
According to our recent poll, 45% of respondents had neither a #CTMS nor an #eTMF system, while only 24% had both.… https://t.co/l4dKC7pBQo
Bioclinica (3 weeks ago)